Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product

CT-P10 (Truxima™) was recently approved as the world's first rituximab biosimilar product in the European Union (EU) and South Korea. To demonstrate biosimilarity of CT-P10 with the reference medicinal product (RMP), extensive 3-way similarity assessment has been conducted between CT-P10, EU-Ri...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:MAbs
Hlavní autoři: Lee, Kyoung Hoon, Lee, Jihun, Bae, Jin Soo, Kim, Yeon Jung, Kang, Hyun Ah, Kim, Sung Hwan, Lee, So Jung, Lim, Ki Jung, Lee, Jung Woo, Jung, Soon Kwan, Chang, Shin Jae
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2018
Témata:
Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5916562/
https://ncbi.nlm.nih.gov/pubmed/29469653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1433976
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky